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RESEARCH PAPERS

Dietary magnesium and copper affect survival time and
neuroinflammation in chronic wasting disease
Tracy A. Nicholsa, Terry R. Sprakerb,c, Thomas Gidlewskia, Bruce Cummingsb,
Dana Hillc, Qingzhong Kongd, Aru Balachandrane, Kurt C. VerCauterena,
and Mark D. Zabelc
a

National Wildlife Research Center, US Department of Agriculture, Animal and Plant
Health Inspection Service, Wildlife Services, Fort Collins, CO, USA;
b
Colorado State University Diagnostic Laboratory, College of Veterinary Medicine,
Colorado State University, Fort Collins, CO, USA;
c
Department of Microbiology, Immunology and Pathology, College of Veterinary
Medicine and Biomedical Sciences, Colorado State University Prion Research Center,
Fort Collins, CO, USA;
d
Departments of Pathology and Neurology & National Center for Regenerative Medicine,
Case Western Reserve University, Cleveland, OH, USA;
e
National and OIE Reference Laboratory for Scrapie and CWD, Canadian Food
Inspection Agency, Ottawa, Ontario, Canada

ABSTRACT. Chronic wasting disease (CWD), the only known wildlife prion disease, affects deer,
elk and moose. The disease is an ongoing and expanding problem in both wild and captive North
American cervid populations and is difficult to control in part due to the extreme environmental
persistence of prions, which can transmit disease years after initial contamination. The role of
exogenous factors in CWD transmission and progression is largely unexplored. In an effort to
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understand the influence of environmental and dietary constituents on CWD, we collected and
analyzed water and soil samples from CWD-negative and positive captive cervid facilities, as well as
from wild CWD-endozootic areas. Our analysis revealed that, when compared with CWD-positive
sites, CWD-negative sites had a significantly higher concentration of magnesium, and a higher
magnesium/copper (Mg/Cu) ratio in the water than that from CWD-positive sites. When cevidized
transgenic mice were fed a custom diet devoid of Mg and Cu and drinking water with varied Mg/Cu
ratios, we found that higher Mg/Cu ratio resulted in significantly longer survival times after
intracerebral CWD inoculation. We also detected reduced levels of inflammatory cytokine gene
expression in mice fed a modified diet with a higher Mg/Cu ratio compared to those on a standard
rodent diet. These findings indicate a role for dietary Mg and Cu in CWD pathogenesis through
modulating inflammation in the brain.
KEYWORDS. Cations, chronic wasting disease, copper, environment, iron, magnesium,
manganese, metals, prion disease

INTRODUCTION
Chronic wasting disease (CWD), the only
known wildlife prion disease, is a progressive
fatal neurodegenerative disease that is transmitted
in the absence of nucleic acids by infectious proteinacious particles that resists protease digestion
(PrPRes).1 Efficient transmission occurs directly
from animal-to-animal,2 and indirectly via the
environment.3 Brain pathology includes PrPCWD
plaques, neuroinflammation, and spongiform
degeneration 4. Since its recognition in the 1960s,
CWD has become a persistent problem in both
wild and captive populations of North American
cervids (deer, elk and moose), has spread to 22
states in the USA and 2 Canadian provinces and
shows no sign of stopping. Once established,
prevalence rates can be as high as 50% in deer,
leading to an overall decrease in cervid populations.5,6 The presence of CWD has been catastrophic to the captive cervid industry, often
requiring the culling of entire herds. The disease
is difficult to control in part because prions are
able to remain infectious in the environment and
transmit disease years after contamination, providing an ongoing reservoir for indirect CWD
transmission.7-10 There are currently no treatments or preventatives available for CWD or any
other prion disease.
Multiple studies have suggested that essential
micronutrients, such as copper (Cu2C) and manganese (Mn2C), may have an influence on the
conversion of PrPC to PrPRes,11-14 with Cu2C chelation resulting in delayed prion disease onset.15

Copper is a normal ligand for PrPC, and Mn2C
has been shown to actively compete for Cu2C
binding sites on PrPC.16-19
To understand the role of environmental and
dietary constituents on CWD infection and pathogenesis, we collected and analyzed water and soil
samples from CWD-positive and negative captive
cervid facilities, as well as from CWD-enzootic
wild areas. Our analysis revealed that water from
CWD-negative sites had significantly higher
magnesium [(Mg)/Cu, Mg/Mn, and Mg/iron
(Fe)] ratios than water from CWD-positive sites,
with the Mg/Cu ratio having the most significant
relevance. The levels Mg in the water were
higher on negative sites and Cu, Mn, and Fe were
all lower on negative sites, although not statistically significant. To further assess the roles of
Mg and Cu in CWD disease progression, a bioassay was conducted in which transgenic mice
expressing elk PrP (Tg 12) were fed a custom
diet devoid of Mg and Cu in combination with
drinking water containing a spectrum of Mg/Cu
ratios. Because the environmental Mg/Cu ratio
had the highest significance, it was selected to be
the focus of this study. Our results demonstrate
that after intracerebral CWD inoculation, (1) Tg
12 mice on diets with the highest Mg/Cu ratio
and lowest Cu concentration had significantly
longer survival times those on lower Mg/Cu
rations and higher levels of Cu; (2) Tg 12 mice
on a high Cu diet produced significantly higher
levels of several inflammatory cytokines when
compared to mice on a low Cu diet; (3) Tg 12
mice on a diet with an optimal Mg/Cu ratio
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showed a lower expression of inflammatory
genes when compared with mice on a standard
rodent diet. Our findings are consistent with the
hypothesis that the observed increase in survival
time in mice on diets with high Mg/Cu ratios is
due to a decrease in neuroinflammation, a hallmark of prion diseases,20,21 since Mg has been
shown to decrease neuroinflammation,22 while
copper does the opposite.23,24

RESULTS
Environmental Samples - ICP Soil
Analysis
Soil levels of copper (Cu), manganese (Mn),
magnesium (Mg), and Iron (Fe) were compared
between CWD-positive and CWD-negative
locations. No significant difference between
sites was found in either the levels of each individual cation (Fig. 1) or the ratios of Mg/Cu,
Mg/Mn, and Mg/Fe (Fig. 2).

Soil Composition Analysis
Analysis was done to determine if soil composition differed between sites, and no significant difference was detected in the relative
amount of organic matter, quartz, silt, and clay
(Table 1).

Environmental Samples - ICP Water
Analysis
ICP-MS analysis of water from the study
locations revealed no statistically significant
differences in individual Mg, Cu, Mn and Fe
concentrations. However, with the exception of
Mg, the metal cation concentrations tended to
be higher on CWD-positive sites (Fig. 3).
When Mg/Cu, Mg/Mn and Mg/Fe ratios were
calculated, CWD-negatives sites all had significantly higher ratios than CWD-positive sites
(Fig. 4).

FIGURE 1. ICP-MS soil concentrations (ppb- parts per billion) of Mg (A), Cu (B), Fe (C) and Mn (D)
from captive white-tailed deer and elk locations (n D16). No significant difference in cation concentration was detected between CWD-positive and CWD-negative locations (Two-tailed Student’s Ttest, a D 0.05) Mg (p D 0.719), Cu (p D 0.580), Fe (p D 0.335) and Mn (p D 0.732).
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FIGURE 2. Soil Mg/cation ratio comparisons between CWD-positive and CWD-negative locations
Mg/Cu (A), Mg/Mn (B), Mg/Fe (C) from captive white-tailed deer and elk locations. No significant difference was detected between any of the groups (Two-tailed Student’s T-test, a D 0.05). Mg/Cu
(p D 0.803), Mg/Mn (p D 0.936), Mg/Fe (p D 0.304).

Transgenic Mouse Bioassay Intracerebral Inoculation
Survival
TG 12 mice IC inoculated with CWD were
euthanized when they became symptomatic. Disease status was confirmed by Western blot
TABLE 1. Soil composition (by percent) at
CWD-positive and negative sites. There was no
statistically significant difference in composition
between positive and negative sites (2-tailed
Student’s T-test, a D 0.05).
Soil
Constituent
Organic
Matter
Quartz
Silt
Clay

Mean % at
CWD- Sites

Mean% at
CWDC Sites

Statistical
Significance

8.28

6.57

p D 0.562

54.8
13.6
31.6

52.8
12.8
34.4

p D 0.674
p D 0.750
p D 0.375

analysis (data not shown). Mice fed the custom
diet with the highest Mg/Cu drinking water ratio
and the lowest concentration of Cu in drinking
water, (Group D), lived significantly longer (average 136 days) than those on custom diets with
more Cu (average 125–128 days) (Table 2).
To examine the role of the individual cations
and Mg/Cu ratio in increased survival time, survival times were plotted against cation concentration or Mg/Cu ratio. Increased survival time
was associated with increased Mg concentration and Mg/Cu ratio, and with decreased Cu
concentration (Fig. 5). Although difficult to
compare, the Mg/Cu ratio had the greatest slope
(0.02600) as compared to Mg alone (0.00007)
and Cu (¡0.00023).

Mouse Brain ICP-MS
Mass spectrometry analysis showed that
the concentration of Cu in the brains of
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FIGURE 3. ICP-MS water concentrations (ppb D parts per billion) of Mg (A), Cu (B), Mn (C) and Fe
(D) from captive white-tailed deer and elk locations. No significant difference in cation concentration
was detected between CWD-positive and CWD-negative locations (Two-tailed Student’s T-test,
a D 0.05). Mg (p D 0.109) Cu (p D 0.227), Mn (p D 0.323), and Fe (p D 0.271).

CWD-negative and CWD- positive mice from
the same treatment group were not significantly different, demonstrating that CWD status did not affect the amount of detectable Cu
in the brain (Fig. 6-A). In contrast, significantly higher Mg levels were observed in
CWD- positive mice from group A (Fig. 6B). The Mg/Cu ratio between CWD-negative
and CWD-positive mice was significantly different only in group A, with the CWD-positive mice having a higher ratio (Fig. 6-C).
The concentrations of Mg, Cu, and the ratio
of Mg/Cu in the brains at terminal stage
CWD-positive mice appeared to remain constant, regardless of survival time (Fig. 7).

RT-PCR
Mice fed the custom diet with the highest
drinking water Cu/Mg ratio, group D, showed
differential gene expression (>2 -fold

change) from mice fed the standard 5001 diet
and water, group E. Both CWD-positive time
points (60 DPI and terminal disease) from
group D, as well as from CWD-negative animals, were compared to the CWD-negative
and positive time points from group E. Comparison of negative controls between each
group did not show much differentiation in
gene expression, with group D having 2 genes
increased, and 3 decreased, as compared to
group E (Fig. 8A, Table 3a). Comparison
between group E negative controls and group
E, 60 DPI CWD-inoculated mice showed
alterations in 14 genes, with 4 up-regulated,
and 10 down-regulated (Fig. 8B, Table 3b) as
compared to negative controls. The group E
terminal mice had 9 genes upregulated and 6
downregulated, as compared to the group E
negative controls (Fig. 8C, Table 3c).
Although the numbers of altered genes is similar, there were only 4 genes in common
between the 2 time points. Group D, 60 DPI
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FIGURE 4. Water Mg/cation ratio comparisons between CWD-positive and CWD-negative locations Mg/Cu (A), Mg/Mn (B), Mg/Fe (C) from captive white-tailed deer locations. A significant difference (*) was detected between all groups, with CWD-negative locations having greater Mg/cation
ratios (Two-tailed Student’s T-test, a D 0.05). Mg/Cu (p D 0.003), Mg/Mn (p D 0.007), Mg/Fe
(p D 0.008).

CWD-inoculated mice showed alterations in 7
genes, with one up-regulated, and 6 downregulated as compared to group E negative
controls (Fig. 8D, Table 3d). In contrast, the
group D terminal mouse comparisons had 13
altered genes, with 4 upregulated and 9
downregulated (Fig. 8E, Table 3e). The two
group D time points had 2 common altered
genes. Group D, 60 DPI mice only shared 4
genes in common with group E, 60 DPI. Terminal mice from groups D and E shared 7
genes in common (ccl-19, ccl-3, ccl-9, csf2,
IL13, Tnfsf-11, Tnfsf-13). The most striking
difference between time points is at 60 DPI,
where group D had far fewer gene alterations
than group E.
To determine if differential gene expression
was associated with disease within group D,
CWD-negative group D control mice were
compared to both 60 DPI and terminal group D
mice. This comparison revealed only 2 gene
alterations at 60 DPI (Fig. 9A, Table 3f), but

13 alterations at terminal disease (Fig. 9B,
Table 3g).

Immunohistochemistry
Glial fibrilary acidic protein (GFAP) staining in the hippcampus was compared between
groups D and E. The hippocampus was
selected for comparison, as it was the most
affected brain region in CWD mouse studies
conducted in this laboratory. Others have
noted the presence of PrPCWD staining in the
hippocampus, however the pattern was different possibly due to differences in inoculum.25,26 None of the CWD-negative controls
for groups D or E (data not shown) showed
any staining for PrPCWD amyloid plaques.
Plaques were visible at DPI 60 in both groups
(data not shown), with group D appearing to
have more staining. At terminal disease plaques could be seen in both groups.
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TABLE 2. Survival time comparisons between test groups inoculated intracerebrally (IC)
with chronic wasting disease. (A) Median survival times, days post inoculation (DPI) Mg/
Cu ratio, and MG and Cu concentration of each CWD-positive treatment group (B). Statistical comparisons between CWD-positive treatment groups. Group D lived signiﬁcantly
longer than several other groups. ppb= parts per billion, * D signiﬁcantly different. (LogRank test, a  0.05)
Test Group
A. Custom
B. Custom
C. Custom
D. Custom
E. 5001
Treatment Group survival times compared

Mg/Cu Ratio

[Mg] ppb

[Cu] ppb

Mean survival DPI and CI

26
9
167
500
162

1,000,000
350,000
1,000,000
1,000,000
2,100,000

38,340
38,340
6,000
2,000
13,000

125 (113–134)
126 (119–137)
128 (124–135)
136 (130–148)
133 (127–136)
pD

D vs. A
D vs. B
D vs. C
D vs. E
A vs. B
A vs. C
A vs. E
B vs. C
B vs. E
C vs. E

All groups showed GFAP expression in the
hippocampus, however group E had more staining at DPI 60 (Fig. 10 B).

Protein Expression
We next investigated whether the increases
in transcripts encoding chemokines and their
receptors and inflammatory cytokines in mice
fed high Cu diets translated into increased
expression of cognate inflammatory cytokines.
We simultaneously measured levels of 11 cytokines in brains from mice fed a high Cu diet
(E) or low Cu diet (D). Of the inflammatory
cytokines analyzed, we detected significant
increases of IFNg and IL-1b in brains of mice
fed a high Cu diet and terminally ill with CWD
over mock-infected controls, whereas mice fed
a high Cu diet and terminally ill with CWD
over mock-infected controls, whereas mice fed
a low Cu diet exhibited no increase in IFNg
and a significant decrease of IL-1b at 60 DPI
and terminal disease (Fig. 11).
We observed no significant difference in
expression of TNFa and IL-6. We detected no
granulocyte-monocyte colony stimulating

0.03*
0.10
0.04*
0.07
0.71
0.03*
0.24
0.76
0.51
0.76

factor (GM-CSF) in any mice from any group.
We also observed significant reduction in
expression of T cell-activating cytokines IL-2,
IL-12p70 and IL-18, as well as the anti-inflammatory Th2 cytokine IL-13, in mice fed low
Cu diets compared to mice fed high Cu diets.
We detected no IL-4 or IL-5 in any mice from
any group.

DISCUSSION
The goal of this work was to determine if
differences observed in Mg and Cu water concentrations on CWD-negative and CWD-positive sites could be translated into a transgenic
mouse bioassay to assess their effects on CWD
progression. Numerous studies have shown that
metals such as manganese and copper alter
prion protein stability, leading to altered levels
in diseased animals.16,27-30 Copper is a common environmental divalent cation and can be
found in varying concentrations in soil and
water,31 is a normal ligand for PrPC, and
increased Cu levels show convincing evidence
for being a factor in CWD propagation.19,32-35
However, little work has been done to
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FIGURE 5. Survival times (DPI-days post inoculation) versus Mg, Cu, or Mg/Cu ratio concentrations in CWDC mouse diet. (A) Mg concentrations low to high, (B) Cu concentrations, low to high
(C) and Mg/Cu expressed as a ratio, low to high. The Mg/Cu ratio showed the most positive influence on survival time (slope: 0.02600), followed by the negative influence of Cu (slope: ¡0.00023),
and a modest increase on survival time by Mg (slope: 0.00007).

specifically assess the levels of cations in the
environment and their impact on CWD.

Environmental Sampling
Our environmental analysis showed no difference between copper (Cu), manganese (Mn),
magnesium (Mg), and iron (Fe) soil levels at
CWD-positive and negative locations. However, Mg was significantly higher at CWD-negative sites in the water, and there was a trend
toward decreased Cu, Mn and Fe levels at these
sites, and increased Cu, Mn and Fe on CWDpositive sites.
Water sources were compared to determine
if the origin of the water, well versus surface
water, had an impact on the cation levels since
metals can leach from pipes into the water.
CWD-negative sites had a greater percentage

of well water sources than CWD-positive sites,
yet had lower levels of Cu indicating that the
increased level of Cu, Fe and Mn seen at
CWD-positive sites was not a result of leaching
from copper supply pipes. A study by Davies
and Brown suggests that increased Mn can help
protect the prion protein from degradation and
increase its infective potential.36 Although not
statistically significant, an increase in Mn was
seen in water from CWD-positive sites.
Although Cu was the cation selected for this
study, it is totally within the realm of possibility that similar survival outcomes could be
observed by interchanging Mn or Fe with the
Cu. If so, it would suggest that redox reactions
with divalent cations, in general, could have
negative impacts on disease progression, survival, and neuroinflammation.
Several studies have implicated clays in
increased environmental prion persistence and
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FIGURE 6. ICP-MS analysis of mouse brains from each group. (A) Cu concentration comparisons
between CWD-negative (¡) and CWD-positive (C) mice from each treatment group. (B) Mg concentration comparisons between CWD- and CWDC mice from each treatment group. (C) Mg/Cu
ratio comparisons between CWD- and CWDC mice from each treatment group. ppb D parts per billion. * D significantly different from matched CWD- matches. (Student’s one-tailed T-test, a  0.05.)

even infectivity.37,38 Soil composition was
compared between positive and negative sites.
The clay fraction levels were similar between
sites suggesting that increased clay composition
was not responsible for the increased incidence
of CWD at the positive locations. A recent
study examining the particulars of clay composition revealed that the type of clay present can
influence CWD persistence.39 However, that
type of analysis was beyond the scope of this
study, and would not explain the bioassay
results where no clay exposure occurred.

Transgenic Mouse Bioassay
Mice fed the lowest concentration of Cu and
highest concentration of Mg, ie the highest Mg/
Cu ratio, lived significantly longer than the other
treatment groups with custom diets and

supplemented drinking water, as well as the
standard rodent diet and water group. Mice were
inoculated with an infectious dose one order of
magnitude lower than what is often utilized in
IC studies (0.1% vs. 1% infected brain homogenate). This was done to try to more closely represent a natural dose. However, we readily
acknowledge that the very nature of IC inoculation precludes it from being a true model for natural infection. It appears that Cu concentration
had the greatest impact on survival, as mice fed
the lowest concentration lived the longest. Mice
fed 6000 ppb had similar survival times indicating a threshold dose between 2000 and 6000
ppb. However, all animals in each group ultimately succumbed to disease. Our results support findings from a previous study using mouse
scrapie which demonstrated a neuroprotective
effect of dietary copper depletion, but an inability to prevent neuronal death.29 However, a
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FIGURE 7. Survival times (DPI-days post inoculation) vs. ICP brain concentrations in CWDC mice.
(A) Mg concentrations low to high, (B) Cu concentrations, low to high (C) and Mg/Cu expressed as
a ratio, low to high. The concentrations of Mg, Cu, or the Mg/Cu ratio found in study mouse brains
did not appear to vary between survival times.

balance is essential, as significant copper depletion can also have detrimental effects such as
spongiosis in the brain.40 Copper also has been
shown to play a role in Alzheimer’s disease
(AD), a close cousin of prion diseases. Increased
Cu has been found in the brains of AD
patients,41 and been shown to increase amyloid
precursor protein (APP) expression 42 and exacerbate both tau and amyloid b pathology,43,44
while copper chelation slowed Alzheimer’s disease progression.45 The presence of redox-active
metals, particularly Cu, has been shown to
induce oxidative stress in the brain.23,24, 46,47
Oxidative stress, in the form of reactive oxygen
species (ROS), hydroxyl radicals, and lipid peroxidation, has been implicated in neurodegenerative disease progression by initiating
inflammation.34,48-52 Studies examining the levels of various cations in CWD-positive and negative animal tissues have shown both Cu
increases and decreases in the blood and brain in

deer, elk, and rodents, complicating interpretation.46,53, 54
Unlike Cu, Mg is not a ligand for binding
sites on PrPC. However, it is an important component for over 300 enzymes such as those that
polymerize RNA and DNA, phosphorylate
molecules, and combat oxidative stress.31 Its
presence has been shown to reduce inflammation 55,56 and have a beneficial effect on diabetes, metabolic syndrome, and arsenic-induced
oxidative stress.57-59 The role of Mg in prion
disease has largely been ignored as it does not
directly bind to the prion protein like Cu or
Mn. However, a study with Alzheimer’s disease patients demonstrated that individuals
who took Mg supplements, had slower cognitive decline than those that didn’t.60
Magnesium ions can reduce inflammatory
responses and neuronal death by antagonizing calcium channels thus preventing
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FIGURE 8. RT-PCR differential gene expression comparing CWD-infected mice from treatment
groups D and E to CWD-negative control mice from group E. CWD-inoculated animals given higher
Cu (ppm), group E, had a greater number of gene expression alterations (14 > 2-fold) at 60 d post
inoculation (DPI), and at terminal disease (15 >2-fold) (A) than group D, which had 7 altered genes
at 60 DPI and 13 at terminal disease (B). Although similar in number, the genes altered at terminal
disease were different between groups E and D.

the release of neurotoxic TNFa and IL-6,
and reducing pro-apoptotic proteins.61-63
Both TNFa and IL-6 protein levels were
reduced in mice fed lower Cu and higher
Mg in this study. Mg levels, overall, are
reduced in patients with AD 54,64 and Mg
supplementation has been suggested as a
therapeutic agent 59,65, 66 An increase in
Mg alone was insufficient to rescue or
prevent death from CWD in this study.
Group E had very high levels of Mg
(2,100,000 ppb), but still did not survive
significantly longer than the other groups.
However, Mg may have played somewhat
of a role in increased survival as there
was no significant difference in survival
time between group C and groups A and
B despite there being over a 6-fold
increase in the copper concentration in A
and B, but the same level of Mg. More
work is warranted to evaluate the effect of
magnesium on CWD and other prion
diseases.

Mouse Brain ICP-MS
Analysis of the brains from 3 randomly
selected mice from each of the 5 treatment
groups and inoculation status did not reflect the
amount of Cu and Mg ingested in drinking water.
Mice consuming higher levels of Cu in their
drinking water did not present with higher Cu
brain levels than those receiving 19 times less,
indicating tightly controlled homeostasis. CWD
status did not affect the amount of Cu detected in
the brain, however, mice with CWD did have
increased Mg levels, with 2 groups having significant differences. Perhaps this reflects an attempt
by the body to combat neuroinflammation, which
is central to prion disease progression.21,67 Studies have shown both increases and decreases in
blood and brain cation levels of prion-positive
vs. negative deer, elk and rodents.46,53, 54 In contrast to our findings, a study examining Mg and
Cu levels in the brain of CWD-negative and positive elk found decreased brain Mg levels in
CWD-positive animals and no difference in
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TABLE 3. Gene alterations >2-fold by comparison group. Table shows gene abbreviation and full
name. CWD- D CWD-negative animals, CWDC D CWD-positive animals
Compared Groups

Gene

a. Group E CWD- vs Group D
CWDCxcl-15
Infng
IL-1b
IL-16
IL-17B

Chemokine (c-x-c motif) ligand 15
Interfuron gamma
Interleukin 1 Beta
Interleukin 16
Interleukin 17 B

ccl-4
ccl-6
ccl-19
ccl-20
Ccr-2
Ccr-4
Cxcl-5
Tnfsf-13b
Fasl
Bmp-2
Spp1
IL-2rg
IL-13
IL-16

Chemokine (C-C motif) ligand 4
Chemokine (C-C motif) ligand 6
Chemokine (C-C motif) ligand 19
Chemokine (C-C motif) ligand 20
Chemokine (C-C motif) receptor 2
Chemokine (C-C motif) receptor 4
Chemokine (c-x-c motif) ligand 5
Tumor necrosis factor (ligand) superfamily member 13b
Fas ligand (TNF superfamily member 6)
Bone morphogenic protein 2
Secreted phosphoprotein 1, OPN
Interleukin 2 receptor gamma
Interleukin 13
Interleukin 16

ccl-3
ccl-9
ccl-19
Ccr-10
Cxcl-15
Tnfsf-11

Chemokine (C-C motif) ligand 3
Chemokine (C-C motif) ligand 9
Chemokine (C-C motif) ligand 19
Chemokine (C-C motif) receptor 10
Chemokine (c-x-c motif) ligand 15
Tumor necrosis factor receptor superfamily member
11b- osteoprotegerin
Tumor necrosis factor (ligand) superfamily member 13
Colony stimulating factor 2 (granulocyte-macrophage)
Oncostatin M
Interfuron gamma
Tumor necrosis factor a
Interleukin 2 receptor gamma
Interleukin 11
Interleukin 13
Interleukin 16

b. Group E CWD- vs Group E
CWDC 60 DPI

c. Group E CWD- vs Group E
CWDC terminal disease

Tnfsf-13
Csf-2
OSM
Infng
TNF
IL-2rb
IL-11
IL-13
IL-16
d. Group E CWD- vs Group D
CWDC 60 DPI
ccl-12
ccl-19
Tnfsf-11

Compared Groups
e. Group E CWD- vs Group D
CWDC terminal disease

Spp1
IL-1b
IL-16
IL-27
Gene

ccl-3

Chemokine (C-C motif) ligand 12
Chemokine (C-C motif) ligand 19
Tumor necrosis factor receptor superfamily member
11b- osteoprotegerin
Secreted phosphoprotein 1, OPN
Interleukin 1 Beta
Interleukin 16
Interleukin 27

Chemokine (C-C motif) ligand 3
(Continued on next page)
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TABLE 3. Gene alterations >2-fold by comparison group. Table shows gene abbreviation and full
name. CWD- D CWD-negative animals, CWDC D CWD-positive animals (Continued)
Compared Groups

Gene
ccl-9
ccl-19
Tnfsf-11
Tnfsf-13
Fasl
Bmp-2
Csf-2
Nampt
IL-5ra
IL-7
IL-13
IL-33

Chemokine (C-C motif) ligand 9
Chemokine (C-C motif) ligand 19
Tumor necrosis factor receptor superfamily member
11b- osteoprotegerin
Tumor necrosis factor (ligand) superfamily member 13
Fas ligand (TNF superfamily member 6)
Bone morphogenic protein 2
Colony stimulating factor 2 (granulocyte-macrophage)
Nicotinamide phosphoribosyltransferase
Interleukin 5 receptor alpha
Interleukin 7
Interleukin 13
Interleukin 33

ccl-1
Spp1

Chemokine (C-C motif) ligand 1
Secreted phosphoprotein 1, OPN

ccl-2
ccl-3
ccl-6
ccl-9
ccl-12
Ccr-1
Ccr-6
Tnfsf-13b
OSM
TNF
IL-5ra
IL-13
IL-33

Chemokine (C-C motif) ligand 2
Chemokine (C-C motif) ligand 3
Chemokine (C-C motif) ligand 6
Chemokine (C-C motif) ligand 9
Chemokine (C-C motif) ligand 12
Chemokine (C-C motif) receptor 1
Chemokine (C-C motif) receptor 6
Tumor necrosis factor (ligand) superfamily member 13b
Oncostatin M
Tumor necrosis factor alpha
Interleukin 5 receptor alpha
Interleukin 13
Interleukin 33

f. Group D CWD- vs Group D
CWDC 60 DPI

g. Group D CWD- vs Group D
CWDC terminal disease

Cu.53 This is not terribly surprising, as elk and
mice likely process and store minerals differently. Altered brain cation levels do not

necessarily provide evidence of a causative
effect, but could simply represent a storage or
processing dysregulation in the animal.

FIGURE 9. RT-PCR differential gene expression comparing CWD-infected group D time points
to the CWD-negative controls from group D. At 60 DPI, mice showed little differentiation from
control animals (A). At terminal disease there was an increase in gene alterations with 13 exhibiting > 2-fold change (B). (20X magnification.)
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FIGURE 10. GFAP staining in the hippocampus of groups E (left column) and D (right column) at
60 d post inoculation (DPI) and at terminal disease in CWD negative (¡) and positive (C) TG12
mice (4X magnification).

RT-PCR
To determine if a decrease in neuroinflammation might be responsible for an increase in survival times, we evaluated the expression of an
array of inflammatory transcripts. We observed

significant changes in the levels of transcripts in
the brain associated with inflammation in mice
fed a high Cu vs. low Cu diet. Even before onset
of clinical prion disease, we detected increased
expression of transcripts encoding chemokines
and their receptors in high Cu diet mice over
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FIGURE 11. Dietary Copper potentiates prion-induced neuroinflammation. Brains from prioninfected mice fed a high Cu diet (solid line connecting squares) or low Cu diet (dotted line connecting dots) were analyzed at 60 DPI or terminal disease for the indicated cytokine production compared to mock-infected control mice fed the same diet (A-G). Data are expressed as fold-change
ratios compared to mock infected controls. *, p < 0.05 comparing cytokine changes of high versus
low Cu-fed mice at the same time point. **, p < 0.01 comparing cytokine changes of high vs. low
Cu-fed mice at the same time point. **, p < 0.01 comparing cytokine levels at 60 DPI to terminal disease of mice fed the same diet.

mock-infected controls, and no increases in chemotaxis transcripts in low Cu diet mice. At terminal stages of CWD, high Cu diet mice also
increased expression of inflammatory transcripts
for Oncostatin M, TNFa, and IFNg. We observed
no such increase in low Cu diet mice.

Protein Expression
Increased inflammatory transcripts translated to increased expression of inflammatory

proteins IFNg, IL-1b and IL-18, as well as T
cell activating cytokines IL2, IL-12p70 and
the anti-inflammatory TH2 cytokine IL-13 in
mice fed a high Cu diet. Conversely, we
observed decreased expression of these cytokines in brains of mice fed a low Cu diet.
Taken together, these data support our
hypothesis that lowering Cu levels in mouse
diets decreases cerebral inflammation resulting in significantly prolonged survival in
prion-infected mice.
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Immunohistochemistry
Glial fibrillary acidic protein (GFAP), an
intermediate filament protein, staining represents expression of the protein by astrocytes.68
The expression of GFAP is utilized as a marker
for reactive gliosis due to disease, CNS injury,
or neurodegeneration.69,70 Mice in group D
showed less GFAP staining at 60 DPI when
compared to group E at the same time point
(Fig. 10 B). When taken into consideration
with the neuroinflammatory gene expression
data, the reduction may be a physical representation of reduced overall brain inflammation
and injury. However, reduction of cellular
GFAP expression has been shown to be
reduced by intravenous administration of Mg in
traumatic brain injury in rats 70 and our data
indicates higher Mg brain concentrations in
CWD-infected mice. Although group E had a
considerably higher concentration of Mg than
group D, it also has a much higher concentration of Cu, which perhaps overwhelmed any
anti-inflammatory effects that Mg might have
conveyed.
Little research has been done to evaluate the
effect of Mg on neurodegeneration considering
its importance in biological functions and its
potential to reduce inflammatory processes. An
increased Mg/Cu ratio altered disease progression by delaying neuroinflammation, and as a
consequence disease progression. The results
of this preliminary study suggest a role for dietary constituents in the progression of CWD
and the importance of feed composition in disease management. The next step in our research
is to test the optimal Mg/Cu ratio in a cervid
species for efficacy. It is our hope that these
findings may lead toward the development of a
cation-modified diet to prevent or reduce CWD
susceptibility in captive facilities.

METHODS AND MATERIALS

CWD-positive captive elk locations and 2 from
CWD-positive wild sites, totaling 11 CWDpositive sites and 5 CWD-negative sites. All of
the negative sites had 2 different water sources
providing 10 different samples, and 4 of the
positive sites had multiple water sources providing a total of 16 different samples. Water
sources included surface sources (streams,
ponds, and wallows), and well sources (waterers). The historical prevalence of CWD at the
positive captive locations ranged between
5–25% and the cervid CWD incidence rates on
the wild sites ranged between 10–30%. There
was no history of CWD at negative sites.

Environmental Sample Analysis - Soil and
Water by ICP-MS
Approximately 50 g of soil was taken from
10 captive white-tailed deer sites and 30 ml of
water was collected from each source and
placed in 50 ml conical tubes containing 3
drops of nitric acid (Sigma) for preservation.
Upon receipt, soil and water samples were sent
to the Colorado State University analytical
chemistry laboratory in Pueblo, Colorado for
inductively coupled plasma mass spectrometry
(ICP-MS) metals analysis. Water samples were
analyzed utilizing EPA method 200.8 71 and
6020.72 Soil samples were analyzed utilizing
EPA method 305173 and 6020A.72

Soil Composition Analysis
To determine soil composition, samples were
sent to the Colorado State University Soil Laboratory in Fort Collins, Colorado for analysis.
Organic matter, (Method 29–3.5.2, WalkelyBlack procedure),74 Quartz (Method 3–5.3),74
silt, and clay constituent percentages were identified (Method 15- hydrometer method).75

Environmental Samples and Locations

Transgenic Mouse Bioassay Intracerebral Inoculation

Soil and water samples were collected from
10 captive white-tailed deer locations (5 CWDnegative, 5 CWD-positive), and water from 4

All procedures involving animals were performed to minimize suffering and were
approved by the Institutional Animal Care and
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Use Committee at the USDA National Wildlife
Research Center in accordance with the USDA
Animal Welfare Act Regulation. CFR, title 9,
chapter 1, subchapter A, parts 1–4. The transgenic mouse line (TG12) utilized in this study
expresses the elk prion protein with methionine/methionine at codon 132. Mice were generated as previously described, and generally
develop disease-associated ataxia at about 120
d post inoculation (DPI) after intracerebral
inoculation (IC) with 1% brain homogenate
from CWD-affected cervids.26 For the IC survival portion of the study, 4 groups of mice
were placed at weaning on a custom Teklad
magnesium (Mg) and copper (Cu)-deficient
diet (Harlan/Teklad) and de-ionized Mg and
Cu-supplemented drinking water, and one
group on Purina 5001 rodent diet (Purina) and
normal drinking water containing negligible
Mg and Cu levels (90 and 4 ppb respectively)
(Tables 4, 5).
Mice were maintained on the diets for 30 d
prior to IC inoculation with either CWD-positive brain homogenate from a terminal elk or
CWD-negative transgenic mouse brain homogenate (NBH). Inoculum was made by diluting
10% (wt/vol) brain homogenate as previously
described 76 and diluted to 0.1% in sterile filtered phosphate buffered saline (PBS) containing 100 units/mL penicillin and 100 mg/mL
streptomycin (Invitrogen) diluted in inoculum
to 1X, then placed at room temperature for
20 min. The 0.1% brain homogenate was
selected to more closely resemble a natural
dose than the common 1%. Mice were anesthetized with isoflurane gas and inoculated IC
TABLE 4. Dietary constituent values in parts per
billion (ppb) for the custom and 5001 diets
Constituent

Custom Diet-ppb

5001 Diet-ppb

Protein
Fat
Potassium
Magnesium
Iron
Zinc
Manganese
Copper
Selenium

177,000,000
52,000,000
9,520,000
0
210,000
57,800
122,000
500
400

285,000,000
135,000,000
11,800,000
2,100,000
270,000
79,000
70,000
13,000
300

with 30 ml of inoculum 3 mm deep through the
coronal suture, 3–5 mm lateral of the sagital
suture. CWD-positive mice from groups A-C
were euthanized at terminal disease when they
presented with severe ataxia. Control mice
from these groups were euthanized at 200 DPI.
Mice from groups D and E were euthanized at
60 DPI, and at terminal disease when they presented with severe ataxia. Control mice from
groups D and E were euthanized at 60 DPI and
at 200 DPI. Brains were removed at euthanasia,
and half frozen at ¡80 C and half fixed in
10% formalin. Disease presence was assessed
in CWD-positive and negative mice by Western blot analysis (data not shown).

Mouse Brain Cation Analysis by ICP-MS
A 10% (wt/vol) brain homogenate (CWDnegative and CWD-positive) was prepared with
100 mg of formalin-fixed brain in de-ionized
water, as described above, for 3, randomly
selected mice from each test group. Sodium
hydroxide (NaOH) (Sigma) was added to each
sample to a final concentration of 1M NaOH
solution to inactive any prions present. Samples
were allowed to sit at room temperature for
10 min and then neutralized to pH 7 by adding
nitric acid. Samples were then sent to the Colorado State University analytical chemistry laboratory in Pueblo, Colorado for ICP-MS analysis
(method 6020A and 3052 72,77) to determine
the Mg and Cu concentrations present.

Quantitative Real-Time Polymerase
Chain Reaction (RT-PCR)
Mouse brains from groups D and E DPI 60,
and terminal disease (including those utilized
in the IHC and protein assay portions), from
groups D and E were prepared for RT-PCR
inflammatory arrays (Table 6). The cost of the
RT-PCR arrays prohibited the examination of
all mice from these groups. The number of
mice used in each group varied, as the quality
of some of the RNA samples was poor and
generated unusable RT-PCR data. Negative
control groups from DPI 60 and terminal mice
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TABLE 5. Magnesium (Mg) and Copper (Cu) levels and number of mice per treatment group with
(C) and without (¡) chronic wasting disease. ppb- parts per billion, Custom-Teklad Mg/Cu deficient
diet and supplemented drinking water 5001-standard Purina rodent chow and regular drinking
water
Test Group

[Mg] ppb

[Cu] ppb

Mg/Cu Ratio

Number of mice CWD C

Number of mice CWD ¡

A. Custom
B. Custom
C. Custom
D. Custom
E. 5001.

1,000,000
350,000
1,000,000
1,000,000
2,100,000

38,340
38,340
6,000
2,000
13,000

26
9
167
500
162

9
8
12
9
9

9
5
6
8
6

were combined for each group, and served as
Group D and E controls respectively for gene
expression analysis. Extraction of RNA for
each sample was done by following the
instructions in the RNeasyÒ Mini kit (Qiagen).
Prior to extraction, 20 mg of brain, and
350 ml of Qiagen buffer RLT with betamercapturethanol (BME) were added to 1.5 ml
tubes with 2.5 mm glass beads, and homogenized with a Blue Bullet homogenizer (NextAdvance) for 2 min on setting 7. Synthesis of
cDNA was done by utilizing the RT2 First
Strand kit (Qiagen) as per directions, from
extracted RNA. Once cDNA was synthesized,
it was frozen at ¡80 C until needed. Premade inflammatory RT-PCR 96-well arrays
were purchased from SABiosciences (PAMM011Z format D). Plates were loaded by with
25 ml per well of a 102 ml of cDNA and
1350 ml of RT2 SYBRÒ Green qPCR mastermix (SABiosciences) mixture. Each plate contained genes for 84 mouse inflammatory
cytokines and receptors that mediate the

TABLE 6. Number of mice for each group
utilized in the inflammatory RT-PCR array and
protein expression assay. With chronic wasting
disease (C) and without (¡). DPI- days post
inoculation
Test Group and CWD Status

Number of mice

D. CWD- controls
D. CWD C DPI 60
D. CWD C Terminal disease
E. CWD- controls
E. CWD C DPI 60
E. CWDC Terminal disease

6
3
2
4
4
4

inflammatory response, as well as 5 housekeeping genes, and 7 genomic DNA, reverse
transcription, and PCR control wells (see supplemental data section for complete list of
genes). One plate per mouse was amplified on
a Bio-Rad CFX96 RT-PCR instrument utilizing the following conditions: Hotstart at 95 C
for 10 min, then 40 cycles at 95 C for 15 sec,
then 60 C for 60 sec with ramp rate set to 1
C/sec. Completed RT-PCR data was exported
from the Bio-Rad CFX96 and uploaded to the
SABiosciences data analysis website (http://
pcrdataanalysis.sabiosciences.com/pcr/arraya
nalysis.php) for analysis.

Immunohistochemistry (IHC)
One brain hemisphere from each of 3 representative mice from the CWD-positive and
negative from groups D and E were examined
by IHC at 60 DPI and terminal disease. The
three brain hemispheres were formalin-fixed
and paraffin-embedded, then sectioned at 5 mm
and placed on positively charged microscope
slides. The slides were deparaffinized and rehydrated in deionized water.
To prepare for PrPCWD visualization, slides
were pre-treated in 95% formic acid (SigmaAldrich, St. Louis, MO) for 5 minutes at room
temperature, rinsed in deionized water and
placed in 0.1 M Tris buffer, pH 7.3. Antigen
retrieval was performed in DAKO Target
Retrieval Solution (DAKO, Denmark) at 121
C for 20 minutes. Slides were stained with a
Leica Bond Max automated immunohistochemistry stainer (Leica Biosystems, UK)
using a combination of a Mouse-on-Mouse
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Polymer IHC kit (Abcam, Cambridge, MA) and
the Bond Polymer Refine Detection kit (Leica)
and visualized by horseradish peroxidase-DAB
chemistry at room temperature. The staining
protocol is as follows with appropriate rinses
between steps: hydrogen peroxide block
(Abcam) 10 minutes, rodent block (Abcam) 30
minutes, mouse anti-prion primary antibody
(F99/97.6.1, VMRD, Pullman, WA) 1:250 dilution for 30 minutes, protein block (Background
Eraser, Biocare Medical, Concord, CA)
10 min., M.O.M. HRP Polymer secondary antibody (Abcam) 15 minutes, Mixed DAB Refine
(Leica) 10 minutes, DAB Enhancer (Leica) 5
minutes. Slides were counterstained with hematoxylin, and PrPCWD was visualized as brownish granular staining.

GFAP
The same mouse brain samples were used as
the PrPCWD IHC above. To stain for glial fibrillary acidic protein (GFAP), a marker for astrogliosis, the formalin-fixed paraffin-embedded
mouse brain tissue was sectioned at 5 mm and
placed on positively charged microscope slides.
Slides were heated at 60 C for 30 minutes and
loaded onto a Leica Bond Max automated
immunohistochemistry stainer (Leica Biosystems, UK). Slides were dewaxed and antigen
retrieval with ER2 solution (Leica) at 95 C for
20 minutes. Anti- GFAP rabbit monoclonal primary antibody (clone SP78, Cell Marque, Rocklin CA) 1:100 dilution was incubated at room
temperature for 30 minutes. Anti-rabbit secondary antibody (Leica) was incubated at room temperature for 25 minutes. The Bond Polymer
Refine Red Detection kit using alkaline phosphatase-fast red visualization was run and the
slides were counterstained with hematoxylin.
Hippocampal regions of the brain were reviewed
for changes in stain intensity as this is the most
affected brain region in this transgenic line.

with following change: protease inhibitor cocktail (Roche) was added to PMCA buffer 1, as
per product instructions, in both steps utilizing
PMCA buffer rather than using PMCA buffer 2
for the second part of the protocol. Brain
homogenate was then stored at ¡80 C until
used in the BioPlex assay.
A mouse Th1/Th2 Extended ProcartaPlexTM
Immunoassay (eBioscience, ref#: EPX11020820-901) was used to measure 11 cytokines
(IL-1b, IL-2, IL-4, IL-5, IL-6, IL-12p70, IL-13,
IL-18, IFN-g, GM-CSF and TNF-a). Brain
homogenate samples were subjected to centrifugation (5000 rpm for 10min at 4 C) and
supernatant was collected and diluted 1:10 for
cytokine analysis. Preparation of samples,
along with kit standards, detection antibody
and streptavidin-PE, were carried out per the
eBioscience magnetic immunoassay protocol.
Standards, samples and a control were run in
triplicate with CWD-negative and positive
samples run on separate 96-well untreated
polystyrene microplates (BD Falcon, 353910).
Cytokine fluorescence intensity was detected
using the BioPlex machine with Luminex Multiplexing Technology and analyzed by BioPlex
Manager software version 5.0.
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